Results 121 to 130 of about 13,887 (161)
Some of the next articles are maybe not open access.
Topotecan-induced Bronchiolitis
Southern Medical Journal, 2004Topotecan HCl is an antitumor drug exhibiting topoisomerase 1-inhibitory activity. Topotecan is used in the treatment of metastatic carcinoma of the ovary and as second-line treatment of small-cell lung cancer. Reported dose-limiting adverse reactions to topotecan are primarily hematologic in nature.
Colin C, Edgerton +2 more
openaire +2 more sources
Activity of topotecan in retinoblastoma
Ophthalmic Genetics, 2004To report our experience with topotecan in children with relapsed/refractory metastatic and intraocular retinoblastoma.Topotecan was administered intravenously as a 30-min infusion at a dose of 2 mg/m2/d for five consecutive days and repeated after three weeks.
Guillermo L, Chantada +5 more
openaire +2 more sources
Topotecan (Hycamptin) and Topotecan‐Containing Regimens in the Treatment of Hematologic Malignancies
Annals of the New York Academy of Sciences, 2000Abstract: Single‐agent topotecan is an active drug in chemotherapy‐naive MDS and CMML and, to a lesser degree, in refractory/relapsed acute leukemias, low‐/intermediate‐grade lymphoma, and myeloma. Its combination with cytosine arabinoside induces complete remissions in high‐risk MDS/CMML.
M, Beran, H M, Kantarjian
openaire +2 more sources